Generation of Xenogenetic antibodies
AssigneeAbgenix, Inc.
InventorsRaju Kucherlapati, Aya Jakobovits, Sue Klapholz, Daniel G. Brenner, Daniel J. Capon
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbgenix, Inc.
InventorsRaju Kucherlapati, Aya Jakobovits, Sue Klapholz, Daniel G. Brenner, Daniel J. Capon
Estimating the term…
The subject invention provides non-human mammalian hosts characterized by inactivated endogenous Ig loci and functional human Ig loci for response to an immunogen to produce human antibodies or analogs thereof. The hosts are produced by multiple genetic modifications of embryonic cells in conjunction with breeding. Different strategies are employed for recombination of the human loci randomly or at analogous host loci. Chimeric and transgenic mammals, particularly mice, are provided, having stably integrated large, xenogeneic DNA segments. The segments are introduced by fusion with yeast spheroplasts comprising yeast artificial chromosomes (YACs) which include the xenogeneic DNA segments and a selective marker such as HPRT, and embryonic stem cells.
A method for producing a transgenic mouse lacking expression of an endogenous immunoglobulin light chain, comprising:
A method for producing a transgenic mouse lacking expression of an endogenous immunoglobulin light chain, comprising:
A method for producing a transgenic mouse and its progeny lacking expression of endogenous immunoglobulin light chains, comprising:
A method for producing a transgenic mouse and its progeny lacking expression of endogenous immunoglobulin light chains, comprising:
A method for preventing the expression of an endogenous immunoglobulin light chain in a transgenic mouse, comprising:
A method for preventing the expression of an endogenous immunoglobulin light chain in a transgenic mouse, comprising:
A method for preventing the expression of endogenous immunoglobulin light chains in a transgenic mouse and its progeny, comprising:
A method for preventing the expression of endogenous immunoglobulin light chains in a transgenic mouse and its progeny, comprising:
A method for producing a mouse embryonic stem cell with at least one inactivated endogenous immunoglobulin light chain locus, comprising deleting the C.kappa. gene from at least one endogenous immunoglobulin light chain locus in the mouse embryonic stem cell to prevent rearrangement of the locus and to prevent the formation of a transcript of a rearranged immunoglobulin light chain, the deletion being effected by a targeting vector comprising a gene encoding a selectable marker.
A method for producing a transgenic mouse wherein the germ cells comprise at least one inactivated endogenous immunoglobulin light chain locus in which the C.kappa. gene is deleted to prevent rearrangement of the locus and to prevent formation of a transcript of a rearranged locus and the expression of an endogenous immunoglobulin light chain from the inactivated locus, said method comprising the steps of:
A method for producing a transgenic mouse and its progeny, wherein the somatic and germ cells comprise at least one inactivated endogenous immunoglobulin light chain locus in which the C.kappa. gene is deleted to prevent rearrangement of the locus and to prevent formation of a transcript of a rearranged locus and the expression of an endogenous immunoglobulin light chain from the inactivated locus, said method comprising the steps of:
A mouse embryonic stem cell with at least one inactivated endogenous immunoglobulin light chain locus in which the C.kappa. gene is deleted to prevent rearrangement of the locus and to prevent formation of a transcript of a rearranged immunoglobulin light chain locus, said inactivated endogenous locus comprising a gene encoding a selectable marker.
A transgenic mouse wherein the germ cells comprise at least one inactivated endogenous immunoglobulin light chain locus in which the C.kappa. gene is deleted to prevent rearrangement and to prevent formation of a transcript of a rearranged locus and the expression of an endogenous immunoglobulin light chain from the inactivated locus.
A transgenic mouse, wherein the somatic and germ cells comprise at least one inactivated endogenous immunoglobulin light chain locus in which the C.kappa. gene is deleted to prevent rearrangement and to prevent formation of a transcript of a rearranged locus and the expression of an endogenous immunoglobulin light chain from the inactivated locus.
A transgenic mouse, wherein the somatic and germ cells comprise inactivated endogenous immunoglobulin loci in which the C.kappa. gene is deleted to prevent rearrangement and to prevent formation of a transcript of a rearranged locus, wherein the transgenic mouse and progeny lack expression of endogenous immunoglobulin light chains.
Dependencies are inferred from the claim text.